iAssay Receives Patent Number 11320418

The United States Patent and Trademark Office (USPTO) has granted patent number 11,320,418 to iAssay Inc., a privately held developer of an open platform, point of care (POC) reader and data management system for remote medical diagnostics.
 
The patent includes nineteen claims, key claims relating to the processing of multiple unique test devices simultaneously in a common drawer, mechanisms for decoding identifiers, and lateral flow test results based on line intensity/color. Embodiments include IT connectivity.
 
“There is a significant unmet need in healthcare today for a single device at the point of care that has the capability to operate multiple different assay modules,” said Lonnie Adelman, founder, and CEO of iAssay. “The development of the iAssay universal handheld diagnostic system has the potential to significantly reduce healthcare costs, simplify care providers’ workflow and ultimately improve patient care.”
 
The company’s growing patent portfolio covers the functionality that enables care providers to perform multiple type assay tests simultaneously by adapting POC test cartridges of various formats and technologies to one device. Claims also cover device wireless communications and plug-in modules that expand the hardware and processing capabilities of the handheld and benchtop models. Further, claims cover the capability to guide the care provider during sample collection and processing, including the ability to decide whether to continue a test or perform certain steps of a test based on interim results as the test progresses.
 
“This patent strengthens the value of our pipeline with near-term intellectual property protection and highlights iAssay’s innovation in a proprietary, multi-use diagnostics for point of care testing,” stated Adelman. “We are excited to bring this groundbreaking innovation to caregivers.”